Literature DB >> 15112356

Catheter-related infection in gastrointestinal fistula patients.

Ge-Fei Wang1, Jian-An Ren, Jun Jiang, Cao-Gan Fan, Xin-Bo Wang, Jie-Shou Li.   

Abstract

AIM: To study the incidence, bacterial spectrum and drug sensitivity of catheter-related infection (CRI) in gastrointestinal fistula patients.
METHODS: A total of 216 patients with gastrointestinal fistulae during January 1998 to April 2001 were studied retrospectively. Two hundred and sixteen catheters of the 358 central venous catheters used in 216 gastrointestinal fistula patients were sent for microbiology analysis.
RESULTS: Ninety-five bacteria were cultivated in 88 catheters (24.6%). There were 54 Gram-negative bacteria (56.8%), 35 Gram-positive bacteria (36.8%), and 6 fungi (6.4%). During the treatment of CRI, 20 patients changed to use antibiotics or antifungal, and all patients were cured. The mean time of catheters used was 16.9+/-13.0 d.
CONCLUSION: CRI is still the common complication during total parenteral nutrition (TPN) treatment in patients with gastrointestinal fistulae, and Gram-negative bacteria are the main pathogens, and bacterial translocation is considered the common reason for CRI.

Entities:  

Mesh:

Year:  2004        PMID: 15112356      PMCID: PMC4622780          DOI: 10.3748/wjg.v10.i9.1345

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  34 in total

1.  Risk factors of catheter-related infections in total parenteral nutrition catheterization.

Authors:  F D Wang; Y Y Cheng; S P Kung; Y M Tsai; C Y Liu
Journal:  Zhonghua Yi Xue Za Zhi (Taipei)       Date:  2001-04

2.  Sequential changes of body composition in patients with enterocutaneous fistula during the 10 days after admission.

Authors:  Xin-Bo Wang; Jian-An Ren; Jie-Shou Li
Journal:  World J Gastroenterol       Date:  2002-12       Impact factor: 5.742

3.  Use of semiautomatic treatment advice to improve compliance with Infectious Diseases Society of America guidelines for treatment of intravascular catheter-related infection: a before-after study.

Authors:  Bart J A Rijnders; Stefaan J Vandecasteele; Eric Van Wijngaerden; Paul De Munter; Willy E Peetermans
Journal:  Clin Infect Dis       Date:  2003-09-10       Impact factor: 9.079

4.  Central line sepsis.

Authors:  Kimberly K Peterson
Journal:  Clin J Oncol Nurs       Date:  2003 Mar-Apr       Impact factor: 1.027

5.  Catheter-related infection in patients on home parenteral nutrition: results of a prospective survey.

Authors:  J-M Reimund; Y Arondel; G Finck; F Zimmermann; B Duclos; R Baumann
Journal:  Clin Nutr       Date:  2002-02       Impact factor: 7.324

Review 6.  Management of catheter-related bacteremia and fungemia in patients on total parenteral nutrition.

Authors:  A F Widmer
Journal:  Nutrition       Date:  1997-04       Impact factor: 4.008

7.  Tissue antioxidant capacity and bacterial translocation under total parenteral nutrition.

Authors:  I Eizaguirre; L Aldámiz; P Aldazábal; N García Urkia; A B Asensio; P Bachiller; J M García Arenzana; J L Ruiz; P Sanjurjo; G Perez Nanclares
Journal:  Pediatr Surg Int       Date:  2001-05       Impact factor: 1.827

Review 8.  Infectious complications of indwelling long-term central venous catheters.

Authors:  D E Clarke; T A Raffin
Journal:  Chest       Date:  1990-04       Impact factor: 9.410

9.  Risk factors and clinical impact of central line infections in the surgical intensive care unit.

Authors:  C Charalambous; S M Swoboda; J Dick; T Perl; P A Lipsett
Journal:  Arch Surg       Date:  1998-11

10.  Randomized controlled trial of heparin for prevention of blockage of peripherally inserted central catheters in neonates.

Authors:  F Kamala; N Y Boo; F C Cheah; K Birinder
Journal:  Acta Paediatr       Date:  2002       Impact factor: 2.299

View more
  2 in total

1.  Enterocutaneous fistulas in the setting of trauma and critical illness.

Authors:  Joseph J Dubose; Jonathan B Lundy
Journal:  Clin Colon Rectal Surg       Date:  2010-09

2.  Effects of recombinant human growth hormone on enterocutaneous fistula patients.

Authors:  Guo-Sheng Gu; Jian-An Ren; Ning Li; Jie-Shou Li
Journal:  World J Gastroenterol       Date:  2008-11-28       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.